CLVS has been beat up for a loooong time.
On a 3 hr chart it appears that we are seeing a bottoming inver H&S formation. Company also is making positive news about Rubraca that just met the primary endpoint of significantly improving Progression-Free Survival vs. Chemotherapy.
Completely a momentum based trade with a tight stop loss.
PS Never ever take any of my posts as financial advice.
On a 3 hr chart it appears that we are seeing a bottoming inver H&S formation. Company also is making positive news about Rubraca that just met the primary endpoint of significantly improving Progression-Free Survival vs. Chemotherapy.
Completely a momentum based trade with a tight stop loss.
PS Never ever take any of my posts as financial advice.